BBIO Past Earnings image   This BBIO past earnings page last updated 8/8/2022
BBIO Past Earnings
PeriodPast Earnings DateAdj. EPS
Q2 20228/4/2022-0.810
Q1 20225/5/2022-1.190
Q4 20212/24/2022-1.010
Q3 202111/4/2021-1.060
Q2 20218/5/2021-0.660
Q1 20215/6/2021-1.180
Q4 20202/25/2021-1.010
Q3 202011/5/2020-0.980
Q2 20208/11/2020-1.030
Q1 20205/13/2020-0.780
Q4 20193/2/2020-0.620
Q3 201911/7/2019-0.510
Q2 20198/14/2019-3.460
BBIO Past Revenue
PeriodPast Earnings DateGAAP
Q2 20228/4/20220.07B
Q1 20225/5/20220.00B
Q4 20212/24/20220.01B
Q3 202111/4/20210.00B
Q2 20218/5/20210.05B
Q1 20215/6/20210.00B
Q4 20202/25/20210.00B
Q3 202011/5/20200.01B
Q2 20208/11/2020NA
Q1 20205/13/2020NA
Q4 20193/2/20200.01B
Q3 201911/7/20190.03B
Q2 20198/14/2019NA
Quotes delayed 20 minutes

Email EnvelopeFree BBIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
BridgeBio Pharma (BBIO) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BBLG Past Earnings
BCAB Past Earnings
BCDA Past Earnings
BCEL Past Earnings
BCLI Past Earnings
BCRX Past Earnings
BDSI Past Earnings
BDSX Past Earnings
BDTX Past Earnings
BDX Past Earnings

BBIO Past Earnings Q&A

What was the best and worst BBIO past earnings results?
For BridgeBio Pharma, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest BBIO past earnings result in our data set was -0.510/share posted in Q3 2019, while the lowest was in Q2 2019 when BBIO posted -3.460/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2022 when BBIO reported 0.07B in revenue, while the quarter with the lowest revenue in our data set was Q2 2020 at NA of revenue.

  Suggested answer: There are 13 BBIO past earnings results in our data set.

On this page we presented the BBIO past earnings date information for BridgeBio Pharma. Reviewing that BBIO Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2019, when BBIO posted adjusted EPS of -0.510/share. Meanwhile the lowest BBIO past earnings result was in Q2 2019, when BBIO posted adjusted EPS of -3.460/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2022 when BBIO reported 0.07B in revenue, while the smallest revenue quarter was Q2 2020 when BBIO reported NA in revenue.

Any self directed investor doing their due diligence on BBIO or any other given stock can benefit from researching all of the BridgeBio Pharma past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate BridgeBio Pharma past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BBIO. Thanks for visiting, and the next time you need to research BBIO past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: RWR YTD Return, NSIT market cap history, Funds Holding NRZ.

 

BBIO Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.